Laszlo Radvanyi
President chez Ontario Institute for Cancer Research
Profil
Laszlo Radvanyi is currently the President & Scientific Director at Ontario Institute for Cancer Research and a Board of Director at Fight Against Cancer Innovation Trust.
He was previously the Senior Vice President & Head-Research at Merck KGaA, Senior Vice President at EMD Serono, Inc. from 2015 to 2018, and the Chief Scientific Officer at Iovance Biotherapeutics, Inc. He holds a doctorate degree from the University of Toronto.
Postes actifs de Laszlo Radvanyi
| Sociétés | Poste | Début |
|---|---|---|
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | President | - |
Fight Against Cancer Innovation Trust
 Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | - |
Anciens postes connus de Laszlo Radvanyi
| Sociétés | Poste | Fin |
|---|---|---|
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Private Equity Investor | 01/04/2018 |
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 02/10/2015 |
| MERCK KGAA | Directeur Technique/Scientifique/R&D | - |
Formation de Laszlo Radvanyi
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| MERCK KGAA | Health Technology |
| Entreprise privées | 3 |
|---|---|
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
Fight Against Cancer Innovation Trust
Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Finance |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
